Frederic Pla - Nov 6, 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief Operating Officer
Signature
/s/ Frederic Pla, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Nov 6, 2023
Transactions value $
$0
Form type
4
Date filed
11/27/2023, 05:41 PM
Previous filing
Sep 11, 2023
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Award $0 +30K +73.97% $0.00 70.6K Nov 6, 2023 Direct F1, F2
holding AKYA Common Stock 20K Nov 6, 2023 By The Pla Family Trust dtd 8/7/14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units shall vest in full on the second anniversary of the first date of the month subsequent to the date of grant.
F2 Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.